Synthetic Minds | Healthcare Enters the Second Half of the Chessboard

Synthetic Minds | Healthcare Enters the Second Half of the Chessboard

The Synthetic Minds newsletter offers short daily insights to get you thinking. If you enjoy it, please forward. All signals are powered by Futurwise. If you need more insights, subscribe to Futurwise and get 25% off for the first three months!

I built the Intelligence Age Scorecard! It will help you understand how ready your organization is for the Intelligence Age.

Today’s topic: Health

Change is Coming to Healthcare, Fast

Europe has authorized a machine to sign off a normal mammogram with no radiologist reading it. The company behind it, Vara, says more than half of Germany's organized screening program already runs on its software.

Set that beside three unrelated results and a shape appears. The things medicine has always been short of have started to become manufacturable.

Vara has received European certification for autonomous triage, so exams its system judges clearly normal are reported without a radiologist reading them.

Google DeepMind has computed the likely effect of all nine billion single-letter changes the human genome can make, and handed the map out free. A rare-disease team used it to find a variant earlier work had missed, then confirmed it at the bench.

A single injection has built cancer-fighting cells inside sixteen patients in Wuhan, treating multiple sclerosis with no manufacturing facility in the loop.

An engineered pig kidney has held a man off dialysis for 271 days, then failed and was removed, after which a human organ took over cleanly.

And a real-time, electronic health record-integrated machine-learning model running in three emergency rooms was successfully deployed in emergency departments to identify patients with opioid use disorder.

That's the technology story. Here is the signal.

None of this is proof that healthcare has changed. It is proof that change is coming, and we should be prepared.

Look at what each step removes: a radiologist from a mammogram, a manufacturing plant from a cell therapy, a dead donor from a transplant, a bench from the search for a diagnosis.

Each builds on the last, one step at a time, until medicine reaches the second half of the chessboard and the steps stop being steps.

We are not there. We are close enough that pretending otherwise is a choice.

Which is why the answer is not speed. Picture a hospital buying an autonomous reader because a rival did, never checking how it reads the women at its clinics. That is an arms race, not a strategy.

These decisions carry long-term unintended consequences and require our slowest thinking. In most industries a bad rollout costs a quarter. Here it would cost a cancer found late.

Predictions have always arrived before observations. That is not new and it changes nothing.

What changes is the ratio. When the rare-disease team found the variant behind an unexplained epilepsy, they took it to the bench and proved it. That second step is the whole discipline, and it matters more as predictions improve, not less.

The other version is visible. A map of nine billion mutations its makers say is not approved for clinical use. A model scoring 0.99 in the lab that correctly identifies four in ten of the patients who walk into an emergency room.

That distance has been named here before.

Prepare for exponential change. Implement it with your slowest thinking. Those two instructions do not resolve, and in healthcare the gap between them is measured in patients.

The Intelligence Age Scorecard

Four of medicine's oldest shortages became manufacturable, and none of it yet proves healthcare has changed. WAVE exists for exactly this gap: are you still watching this converge, or should your organization already be adapting to it?

Benchmark your readiness for the next two quarters, and the next five years, with the Intelligence Age Scorecard.

If this newsletter was forwarded to you, you can sign up here.

Thank you.
Mark